CIPLA - IntraDay Trade Analysis with Live Signals
Back to ListIntraDay Trade Rating: 3.5
| Stock Code | CIPLA | Market Cap | 1,07,104 Cr. | Current Price | 1,326 ₹ | High / Low | 1,673 ₹ |
| Stock P/E | 23.4 | Book Value | 412 ₹ | Dividend Yield | 0.98 % | ROCE | 20.1 % |
| ROE | 16.0 % | Face Value | 2.00 ₹ | DMA 50 | 1,433 ₹ | DMA 200 | 1,490 ₹ |
| Chg in FII Hold | -0.61 % | Chg in DII Hold | 0.47 % | PAT Qtr | 822 Cr. | PAT Prev Qtr | 1,211 Cr. |
| RSI | 29.5 | MACD | -44.6 | Volume | 16,74,949 | Avg Vol 1Wk | 19,84,800 |
| Low price | 1,282 ₹ | High price | 1,673 ₹ | PEG Ratio | 1.28 | Debt to equity | 0.00 |
| 52w Index | 11.2 % | Qtr Profit Var | -42.9 % | EPS | 57.2 ₹ | Industry PE | 29.1 |
📊 Analysis: CIPLA shows weak-to-neutral signals for intraday trading. RSI at 29.5 indicates oversold conditions, while MACD at -44.6 confirms strong bearish momentum. Current price (1,326 ₹) is below both 50 DMA (1,433 ₹) and 200 DMA (1,490 ₹), reflecting short-term weakness. Volume (16.7 lakh) is lower than the weekly average (19.8 lakh), limiting intraday volatility. Despite strong fundamentals, recent profit decline and weak technicals suggest caution.
💰 Optimal Buy Price: Around 1,315–1,330 ₹ (near current levels with support from 1,300 ₹).
📈 Profit-Taking Exit Levels: 1,345–1,360 ₹ (short-term resistance zone).
📉 Stop-Loss / Loss Protection: 1,305 ₹ (below intraday support).
⏱️ If Already Holding: Consider exiting if price fails to sustain above 1,326 ₹ or if MACD continues bearish. If momentum improves with volume support, ride till 1,345–1,360 ₹ before booking profits.
Positive
- Strong ROCE at 20.1% and ROE at 16% indicate efficient capital usage.
- Debt-free balance sheet (Debt-to-equity 0.00) adds financial stability.
- EPS of 57.2 ₹ supports valuation strength.
- DII holdings increased (+0.47%), showing domestic investor confidence.
Limitation
- Price trading below both 50 DMA and 200 DMA indicates bearish trend.
- RSI at 29.5 shows oversold conditions, but momentum remains weak.
- MACD strongly negative (-44.6) signals short-term weakness.
- Quarterly PAT declined (822 Cr. vs 1,211 Cr.), showing earnings pressure.
- 52-week index at 11.2% indicates stock is far below its peak levels.
Company Negative News
- No major external negative news reported, but profit decline raises concerns.
Company Positive News
- Strong fundamentals with debt-free status and efficient capital usage.
- Domestic institutional investors increased stake, reflecting confidence.
Industry
- Industry PE at 29.1 vs stock PE at 23.4 indicates undervaluation.
- Pharmaceutical sector remains supported by global healthcare demand.
Conclusion
⚡ CIPLA is a cautious candidate for intraday trading today. Buy near 1,315–1,330 ₹ with profit targets at 1,345–1,360 ₹ and stop-loss at 1,305 ₹. If already holding, monitor RSI and MACD closely and exit near resistance levels. Strong fundamentals support the stock, but weak technicals and profit decline limit upside potential.